The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

37 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
5
Identification of Potential Off-target Toxicity Liabilities of Catechol-O-methyltransferase Inhibitors by Differential Competition Capture Compound Mass Spectrometry.EBI
Caprotec Bioanalytics
16
Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.EBI
Merck
8
Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.EBI
Ludwig-Maximilians University
6
Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors.EBI
Ludwig-Maximilians-Universit£T M£Nchen
37
Influence of conformation on GRIND-based three-dimensional quantitative structure-activity relationship (3D-QSAR).EBI
University of Turin
21
GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC.EBI
Casmedchem Laboratory
10
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.EBI
Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil
13
The biology and chemistry of hyperlipidemia.EBI
Sinhgad College of Pharmacy
4
Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.EBI
University of Eastern Piedmont
22
Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors.EBI
F. Hoffmann-La Roche
6
Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.EBI
Institute of Microbial Chemistry
5
Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.EBI
Institute of Microbial Chemistry
6
 
Potency and inactivation rates of analogues of an irreversible inhibitor of vertebrate oxidosqualene cyclaseEBI
TBA
2
 
Inhibition of oxidosqualene cyclase by substituted quinolizidinesEBI
TBA
16
 
Inhibition of 2,3-oxidosqualene cyclase by N-alkylpiperidinesEBI
TBA
3
 
2,3:18,19-dioxidosqualene: synthesis and activity as a potent inhibitor of 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomesEBI
TBA
25
Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.EBI
Università
13
Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity.EBI
Laboratoire Glaxosmithkline
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
3
Oxidosqualene cyclase inhibitors as antimicrobial agents.EBI
University of Utah
28
Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase.EBI
Albert-Ludwigs-University of Freiburg
27
Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket.EBI
F. Hoffmann-La Roche
4
Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase derived by consideration of inhibitor pK(a).EBI
AstraZeneca
20
Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.EBI
North-West University
7
A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase.EBI
AstraZeneca
27
Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol EBI
Lieber Institute For Brain Development
2
Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles.EBI
Zeneca Pharmaceuticals
7
29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.EBI
Università
7
Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.EBI
Simon Fraser University
20
Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.EBI
Laboratoires Fournier
42
NAD-based inhibitors with anticancer potential.EBI
University of Minnesota
3
Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.EBI
Hokkaido University
16
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.EBI
The University of Queensland
4
NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.EBI
National Institute of Advanced Industrial Science and Technology (Aist)
28
Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.EBI
Lieber Institute For Brain Development
12
Squalene analogues containing isopropylidene mimics as potential inhibitors of pig liver squalene epoxidase and oxidosqualene cyclase.EBI
State University of New York
8
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.EBI
Marion Merrell Dow Research Institute